NCT04574999View on ClinicalTrials.gov

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

January 25, 2008

Primary Completion Date

February 23, 2009

Study Completion Date

February 23, 2009

Conditions
Vaginal Atrophy
Interventions
DRUG

Estriol

Gel for vaginal application

OTHER

Placebo

Gel for vaginal application

Trial Locations (12)

18014

Complejo Hospitalario Virgen de las Nieves, Granada

28034

Hospital Ruber Internacional, Madrid

28040

Fundación Jiménez Díaz, Madrid

28046

Complejo Universitario La Paz, Madrid

30120

Hospital Universitario Virgen de la Arrixaca, Murcia

33006

Hospital Universitario Central de Asturias, Oviedo

36200

Hospital do Meixoeiro, Vigo

39300

Hospital Sierrallana, Torrelavega

46010

Hospital Clínico Universitario de Valencia, Valencia

46600

Hospital la Ribera de Alzira, Valencia

08022

Centre Mèdic Teknon S.L., Barcelona

08025

Fundació de Gestió Sanitària de l'Hospital de la Santa. Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Italfarmaco S.A

INDUSTRY

NCT04574999 - Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy. | Biotech Hunter | Biotech Hunter